Timothy Cser- Senior Technology Specialist, MilliporeSigma
In the pharmaceutical industry, ensuring the quality and safety of products is paramount. As part of this commitment, regulatory bodies and industry standards have established guidelines for monitoring microbial contamination in cleanrooms and controlled environments. Two significant standards in this area are ISO (International Standards Organization) 14698 and EN (European Norm/ Standard) 17141, which provide frameworks for assessing and managing microbial contamination. Additionally, data integrity is a critical aspect that underpins compliance with these standards, ensuring that data generated during monitoring processes is accurate, reliable, and secure. While EN 17141 is a European norm and not a North American or U.S. standard, many global firms need viable samplers to meet both.
Understanding ISO 14698
ISO 14698 is an international standard that outlines the requirements for the assessment and control of microbial contamination in cleanrooms and controlled environments. This standard is particularly relevant for organizations involved in the manufacture of sterile products, where airborne microorganisms can pose significant risks to product quality and patient safety. It requires the viable sampler to strike a balance between collection efficiency (how well it collects small particles out of the air) and biological efficiency (once collected, how well those microbes grow).
ISO 14698 is divided into two parts:
ISO 14698-1 focuses on the general principles of microbial monitoring and provides guidelines for establishing a monitoring program. It emphasizes the importance of risk assessment in determining the appropriate monitoring strategy, including the selection of sampling locations, frequency, and methods. ISO 14698-2 addresses the evaluation of microbial contamination data, providing statistical methods for data interpretation. It emphasizes the need for a robust data management system to ensure that microbial monitoring results are accurately recorded, analyzed, and reported.
The Role of EN 17141
EN 17141 complements ISO 14698 by providing specific requirements for the performance of microbial air samplers used in cleanrooms and controlled environments. It is particularly important for ensuring that air monitoring devices meet defined performance criteria and are suitable for regulatory compliance.
Among the key aspects of EN 17141 is the performance of microbial air samplers. It specifies the minimum requirements, including sampling efficiency, flow rate accuracy, and the ability to recover viable microorganisms. A sampler should be validated by a suitably competent external body, and scheduled maintenance and calibration of the operating parameters associated with the air flow rate through the sampler and the associated time control must be conducted. To ensure traceability, the standard emphasizes the importance of maintaining thorough documentation of all validation activities, including calibration certificates and performance verification reports. This documentation is essential for demonstrating compliance during regulatory inspections.
Data Integrity: A Cornerstone of Compliance
Data integrity refers to the accuracy, consistency, and reliability of data throughout its lifecycle. It is critical to ensure that all information generated during the manufacturing and monitoring processes is trustworthy and compliant with regulations. Key principles of data integrity include ALCOA+, a framework widely recognized in the pharmaceutical industry, standing for Attributable, Legible, Contemporaneous, Original, Accurate plus Complete, Consistent, Enduring, and Available. Each of these principles reinforces the need for high-quality data that can withstand scrutiny during audits and inspections. Furthermore, with the increasing reliance on electronic systems for data collection and analysis, manufacturers must ensure that their electronic data management systems are validated and compliant with regulations such as 21 CFR Part 11. This includes implementing controls for user access, audit trails, and data encryption to safeguard against unauthorized changes. Ensuring data integrity also requires a culture of compliance within the organization. Regular training and awareness programs for employees involved in data generation and management are essential to reinforce the importance of accurate data recording and reporting.
Integrating ISO 14698, EN 17141, and Data Integrity
Implementing a risk-based approach to microbial monitoring, as outlined in ISO 14698, prompts organizations to prioritize their efforts based on potential contamination risks. This approach should be supported by data integrity practices to ensure that all data generated during monitoring is accurate and reliable. Compliance with EN 17141 ensures that microbial air samplers and other monitoring equipment meet performance criteria. Coupled with strong data integrity practices, organizations can confidently rely on the data generated by these devices for decision-making and regulatory reporting.
Integrating ISO 14698, EN 17141, and data integrity practices creates a comprehensive framework for managing microbial contamination in pharmaceutical companies. By implementing robust data management systems, organizations can enhance their monitoring processes and ensure regulatory compliance. The combination of ISO 14698, EN 17141, and data integrity principles fosters a culture of continuous improvement within pharmaceutical companies. Regular reviews of monitoring programs, data management practices, and compliance efforts can help identify areas for improvement and ensure ongoing adherence to regulatory expectations.
As the pharmaceutical industry continues to evolve, maintaining a strong focus on data integrity will be critical for safeguarding product quality and ensuring patient safety. By prioritizing these standards and principles, pharmaceutical companies can build a solid foundation for effective microbial monitoring and data management, ultimately contributing to the overall integrity of the industry.
Subscribe to our e-Newsletters.
Stay up to date with the latest news, articles, and events. Plus, get special
offers from American Pharmaceutical Review delivered to your inbox!
Sign up now!